MEGAN MCNAMARA: Open Payments
NPI 1255757936 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,355 in 100 payments from 18 companies in 2025. Trend: 2023 $2,029 · 2024 $2,376 · 2025 $2,355
Food & beverage: $2,287Education: $68
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $469 |
| Janssen Biotech, Inc. | 15 | $276 |
| Regeneron Healthcare Solutions, Inc. | 9 | $275 |
| Novartis Pharmaceuticals Corporation | 6 | $239 |
| GENZYME CORPORATION | 5 | $207 |
| Amgen Inc. | 8 | $182 |
| LEO Pharma Inc. | 7 | $162 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $129 |
| Lilly USA, LLC | 5 | $102 |
| Galderma Laboratories, L.P. | 4 | $89 |
Products named: DUPIXENT, RINVOQ, TREMFYA, OTEZLA, Rhapsido, SKYRIZI, ANZUPGO, NEMLUVIO.
Industry payments across NC — which companies pay providers there.
